Home › Essential Thrombocythemia
Pag-aaral pangklinika para sa Essential Thrombocythemia na nagre-recruit sa U.S.
16 pag-aaral para sa Essential Thrombocythemia ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY7 pag-aaral
- Durham, NC6 pag-aaral
- Mountain View, CA4 pag-aaral
- Salt Lake City, UT4 pag-aaral
- Chicago, IL4 pag-aaral
- Nashville, TN4 pag-aaral
- Miami, FL4 pag-aaral
- Baltimore, MD4 pag-aaral
- Boston, MA4 pag-aaral
- Irvine, CA3 pag-aaral
- Kansas City, MO3 pag-aaral
- Columbus, OH3 pag-aaral
- Houston, TX3 pag-aaral
- St. Louis, MO3 pag-aaral
- Cleveland, OH3 pag-aaral
- Los Angeles, CA3 pag-aaral
Ayos sa estado
- California7 pag-aaral
- Florida5 pag-aaral
- Illinois4 pag-aaral
- Kansas3 pag-aaral
- Maryland4 pag-aaral
- Massachusetts4 pag-aaral
- Missouri3 pag-aaral
- New York7 pag-aaral
- North Carolina8 pag-aaral
- Ohio5 pag-aaral
- Pennsylvania4 pag-aaral
- Tennessee4 pag-aaral
- Texas4 pag-aaral
- Utah4 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06661915Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT04282187A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07623200A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07008118Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT07441694Registry of Older Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 65 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT01137825A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT06034002A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 2, 2026 · NCT06351631Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT06063486An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 10, 2026 · NCT05123365MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 23, 2026 · NCT07362225Ruxolitinib in Thrombocythemia and Polycythemia Vera
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 8, 2026 · NCT04644211MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 17, 2025 · NCT06541249Two Step Haplo With Radiation Conditioning
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2025 · NCT05031897Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 27, 2025 · NCT01137643Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update May 3, 2024 · NCT06218628Mula sa ClinicalTrials.gov, na-kuha noong Okt 2, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.